Science & Health
The headline writes itself easily, and badly: Cannabis addicts one in nine seniors. The actual finding from UC San Diego researchers is more specific, more contested, and more useful than that — if you are willing to sit with the nuance for a moment.
According to research published by UC San Diego, approximately one in nine adults over 50 who use cannabis meet the clinical criteria for Cannabis Use Disorder (CUD) — a diagnostic category from the DSM-5 (the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) that encompasses a spectrum of problematic patterns, from mild to severe. The study drew on a substantial sample of older adults and represents one of the more focused examinations of cannabis-related harm in this age group to date.
What the Criteria Actually Measure
Cannabis Use Disorder is not simply a synonym for dependence or addiction, though severe cases can involve both. The DSM-5 diagnosis applies when a person meets at least two of eleven criteria within a twelve-month period — criteria that include things like using more than intended, failed attempts to cut down, continued use despite relationship problems, or neglecting responsibilities. Two criteria qualifies as mild CUD. Eleven would be, by any measure, severe.
That distinction matters enormously when reading a statistic like "one in nine." It means the figure almost certainly includes a large proportion of mild cases — people who perhaps use more cannabis than they planned on a given weekend, or who find cutting back harder than expected. It does not tell us how many are experiencing clinically significant distress or functional impairment, which is the part of the diagnosis that typically drives intervention.
Researchers and clinicians have long debated whether the DSM-5 CUD criteria, designed in an era when cannabis was universally illicit and largely unstudied in older populations, capture meaningful harm as well as they capture patterns that simply look unusual to a framework built around abstinence. That debate is unresolved.
Why Older Adults Are a Specific Concern
The focus on adults over 50 is not arbitrary. Cannabis consumption in this demographic has grown substantially across jurisdictions where access has expanded — whether through medical programmes, adult-use frameworks, or decriminalisation. Older adults often come to cannabis later in life, sometimes as an alternative to prescribed medications, and with less familiarity with contemporary product potency. Average THC concentrations in regulated markets have risen significantly over the past two decades, meaning someone returning to cannabis after a long gap may encounter a very different product than they remember.
There are also pharmacological reasons for caution. The endocannabinoid system — the network of receptors in the body and brain that THC and other cannabinoids interact with — undergoes changes with age, as do liver metabolism rates and the likelihood of polypharmacy (using multiple prescription medications simultaneously). Interactions between cannabis and common medications, including blood thinners and some cardiac drugs, are an active area of clinical research.
None of this means older adults should not use cannabis. It means the conversation between a consumer and their GP is more consequential than it might be at thirty.
A Harm Reduction Reading
From a harm reduction perspective — the approach that prioritises reducing negative consequences over demanding abstinence — a finding like this is useful precisely because it identifies a group that may benefit from more tailored information and support, not because it confirms a moral judgement about cannabis use.
In Malta, where adult-use cannabis is regulated under Chapter 628 of the Laws of Malta and operates through a network of Cannabis Harm Reduction Associations (CHRAs) — member-based, non-profit clubs licensed by ARUC (Authority on the Responsible Use of Cannabis), Malta's regulatory body for adult cannabis — older consumers represent a growing share of membership at some associations. Staff at CHRAs are not clinicians, but harm reduction conversations, including flagging interactions with medications or discussing consumption frequency, fall within the spirit of the framework's design, as outlined in our guide to Malta cannabis law.
Whether associations have the resources and training to consistently provide that kind of support is a separate question — one worth asking as membership demographics continue to shift.
The Methodological Caveat
The UC San Diego study's limitations are worth naming. Research on older adult cannabis use faces a persistent recruitment problem: this population is historically underrepresented in cannabis studies, and self-selection bias — the tendency for people who feel comfortable disclosing cannabis use to be overrepresented in samples — can skew estimates in either direction. The specific methodology, sampling frame, and how CUD severity was distributed across the one-in-nine figure are details that matter for interpreting the headline number, and the original source material available for this article does not allow full evaluation of those elements.
What the finding does establish clearly enough is that older adults are not a risk-free population for cannabis-related harm, and that the assumption that cannabis problems are primarily a concern for young people is overdue for revision.
The more useful question for regulators, clinicians, and harm reduction practitioners is not whether one in nine is a worrying number — it is what kind of support structure exists for the people it describes. A mild CUD finding in isolation is a data point. What happens next depends entirely on whether anyone is paying attention.
Sources:
UC San Diego Today
Featured image: Photo by Kindel Media on Pexels
Members Discussion